Gene thepapy of (selected) neurological diseases

Genov terapie dle definice Evropsk lkov agentury je lba na principu vloen rekombinantnho genu do tla pacienta za elem lby, profylaxe i diagnostiky. V poslednch letech narst poet klinickch studi i poet registrovanch genovch terapi, a to zejmna u monogenn podmnnch vzcnch nemoc. Prvnmi pklady na poli neurologie je genov terapie pro spinln svalovou atrofii, dle genov terapie pro primrn poruchu syntzy biogennch amin (deficit dekarboxylzy aromatickch L aminokyselin - AADC) a genov terapie pro metachromatickou leukodystrofii. V USA je i registrovna genov terapie pro Duchennovu svalovou dystrofii a pro X-vzanou adrenoleukodystrofii. V klinickch studich je ji genov terapie syndromu Dravetov, Leberovy hereditrn optick neuropatie a nkterch typ mukopolysacharidz, dle i genov terapie u nkterch typ pletencovch svalovch dystrofi a u amyotrofick laterln sklerzy s vazbou na SOD1 gen. Efektivita ale i profil nedoucch ink genov terapie jsou vdy specifick k dan diagnze i livmu ppravku. Vysok finann nkladnost a etick otzky genov terapie ekaj na celospoleenskou diskuzi.

Authors

Publication Details

Journal
Neurologie pro praxi
Published
2025-09-29
DOI
https://doi.org/10.36290/neu.2025.004
Primary Topic
Genetics and Neurodevelopmental Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gene thepapy of (selected) neurological diseases

Tomáš Honzík, Přemysl Jiruška, Jana Haberlová
Neurologie pro praxi
Genetics and Neurodevelopmental Disorders
article

Gene thepapy of (selected) neurological diseases

Tomáš Honzík, Přemysl Jiruška, Jana Haberlová
article en

Abstract

Genov terapie dle definice Evropsk lkov agentury je lba na principu vloen rekombinantnho genu do tla pacienta za elem lby, profylaxe i diagnostiky. V poslednch letech narst poet klinickch studi i poet registrovanch genovch terapi, a to zejmna u monogenn podmnnch vzcnch nemoc. Prvnmi pklady na poli neurologie je genov terapie pro spinln svalovou atrofii, dle genov terapie pro primrn poruchu syntzy biogennch amin (deficit dekarboxylzy aromatickch L aminokyselin - AADC) a genov terapie pro metachromatickou leukodystrofii. V USA je i registrovna genov terapie pro Duchennovu svalovou dystrofii a pro X-vzanou adrenoleukodystrofii. V klinickch studich je ji genov terapie syndromu Dravetov, Leberovy hereditrn optick neuropatie a nkterch typ mukopolysacharidz, dle i genov terapie u nkterch typ pletencovch svalovch dystrofi a u amyotrofick laterln sklerzy s vazbou na SOD1 gen. Efektivita ale i profil nedoucch ink genov terapie jsou vdy specifick k dan diagnze i livmu ppravku. Vysok finann nkladnost a etick otzky genov terapie ekaj na celospoleenskou diskuzi.

Neurologie pro praxiVol. 26(4)
Openalex Percentile: Top 71%
Genetics and Neurodevelopmental Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.